Only one SNV showed a nominally significant allele frequency difference (rs6489695, p = 0.03).
Excerpts
showed that an increase of 8 Gy resulted in a highly significant improvement in freedom from BF (70% and 64%, respectively ( p = 0.03)) for patients at intermediate to high risk, which is consistent with our study in freedom from recurrence ( Pollack et al., 2002 ; Kuban et al., 2008 ).
The P154L substitution, which partially reduced protein interaction, was also borderline significant ( p = 0.03) in its chlorosis response.
In addition, the FAR variant caused a nominally significant (p = 0.03) effect on OLE1 but not on SDS23 (p = 0.7), in agreement with our yeVenus reporter assay ( S4 Fig ).
More interesting, ELHB1L1 , another gene of the risk model, revealed a clear trend, but the risk-score is more meaningful ( P = 0.03).
In the CARDIoGRAMplusC4D consortium, there was a nominally significant association with coronary artery disease (OR per minor allele, 0.98; 95% CI, 0.96-1.00; P = .03).
There was an increasing trend ( p = 0.03) in the overall value across three independent groups based on the degree of FIT contract design, and the NEPT construct demonstrated a comparable validity to the ZUF‐8 construct.
1 ), with a highly significant 5.75-fold difference in IC 50 (Table 1 , p < 0.03, two-tailed t-test).
Although this was only a marginal trend (p < 0.03) in this small cohort, this phenomenon is notable.
We also observed higher insulin levels in LoF heterozygotes and homozygotes in the first 30 min of the test (β=0.59, p =2.6×10 –3 ) and a nominally significant trend toward elevated insulin levels throughout (β=0.34, p =0.03).
Interestingly, at the same time, marginally significant reductions were seen in HbA 1c ( p = 0.03) and leptin levels ( p = 0.03).
The differences between warm and recovery phase were only marginally significant ( p < 0.03) for trial 3 samples.
showed a trendp = 0.03
Post-hoc analysis showed a trend toward increased external rotation (normalizing the movement pattern) after the intervention (T1–T2, p = 0.03, 64–100% of the movement cycle), which was not maintained at follow up (T1–T3, p > 0.05; T2–T3, p = 0.01, 72–100% of the movement cycle) (Fig. 5 A).
In the combination therapy cohort, we observed a significant trend of a lower score toward an enhanced survival (Tarone’s trend test P = 0.03; median OS = 41, 22, and 20 months for high-, intermediate-, and low-score strata, respectively; see Fig. 5 c).
approached significancep = .03
65.08% respectively), and indeed results approached significance (X 2 = 4.59, p = .03).
However, for those who were ever smokers, we identified a marginally significant association between genetically predicted T2DM risk and lung cancer risk (OR = 0.92; 95%CI = 0.85–0.99; p = 0.03) although no significant association was observed in never smokers ( OR = 1.00; 95%CI = 0.93–1.07; p = 0.96; P heterogeneity = 0.13).
Given the multiple hypothesis testing involved in this procedure and the modest significance of the difference ( p = 0.03), this should probably be taken with a grain of salt.
After splitting these items into two each (one for PD and one for PAD) the overall item-trait interaction was somewhat significant (P = 0.03), whereas the overall item residual mean and standard deviation, as well as reliability, showed some improvement (Table 2 ).
Participants in the Sativex group demonstrated a pattern of improved cognitive performance as measured by the QbTest, nominally significant improvements in symptoms of hyperactivity/impulsivity ( P =.03), and trends toward improvement for inattention and emotional lability.
Data for the intervention group show a significant trend of better medication intake (I 2 = 65%; DME = −0.31; IC of 95% = −0.57, −0.04; p = 0.03).
The only dose intensity measure predicting a higher risk of relapse on both studies was higher mercaptopurine dose intensity, but this did not reach statistical significance ( P =0.03 T15; P =0.07 T16).
A mildly significant decrease in triglyceride level was only observed in the standard-dose group ( P = 0.03).
did not reach statistical significancep -value = 0.03
SIRs by Time after Cholecystectomy The risk of ovarian cancer increased by 35% (95% CI 2% to 77%) in the first 6 months after cholecystectomy (95% CI did not include 1), but the risk increase did not reach statistical significance after multiplicity adjustment ( p -value = 0.03, Table 1 ).
In contrast, we observed a significant but transient increase in CTLA-4 + CD4 + T cells at C2 (fold change: 1.5, p = 0.004) and a trend for an increase of CTLA-4 + CD8+ T cells at C2 which did not reach statistical significance ( p = 0.03).
The difference between pentads 2 and 3 is borderline significant ( p = 0.03).